Illustration by Ryoko Hamaguchi | Stanford Class of 2015


2016 Stanford Drug Discovery Conference

March 29, 2016

Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our speakers in drug discovery. A broad range of policy, research and venture topics covered.

The audience includes industry leaders from Silicon Valley and a healthy mix of physicians and scientists around the country.

Keynote Speaker

Christopher P. Austin, MD

Director
National Center for Advancing Translational Sciences

Norman Stockbridge, MD, PhD

Director
Division of Cardiovascular and Renal Products, FDA/CDER

Jennifer Grandis, MD

Assoc Vice Chancellor, Clinical and Translational Research; Director, Clinical and Translational Science Institute
UCSF School of Medicine

Aarif Khakoo, MD

Vice President, Research, and Site Head
Amgen South San Francisco
 

Amato Giaccia, PhD

Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology
Stanford University School of Medicine
 

Kevin Grimes, MD

Associate Professor (Teaching) of Chemical And Systems Biology
Stanford University School of Medicine

Keynote Speaker

Brian Kobilka, MD

Helene Irwin Fagan Chair in Cardiology and Professor of Molecular & Cellular Physiology
Stanford University School of Medicine

Robert Harrington, MD

Chair, Department of Medicine
Arthur L. Bloomfield Professor of Medicine, Stanford School of Medicine

Sanjay Malhotra, PhD

Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology)
Stanford University School of Medicine

Bradley P. Morgan, PhD

Vice President
Drug Discovery & Early Development
Cytokinetics, Inc.

Chaitan Khosla, PhD

Wells H. Rauser and Harold M. Petiprin Professor In the School of Engineering and Professor of Chemistry
Director, Stanford ChEM-H

Kelly Shepard, PhD

Senior Science Officer, Discovery and Translation, California Institute for Regenerative Medicine

Keynote Speaker

Jessica L. Mega, MD, MPH

Chief Medical Officer
Verily

 

Charles Homcy, MD

Venture Partner
Third Rock Ventures

Russ Altman, MD, PhD

Kenneth Fong Professor and Professor of Bioengineering, of Genetics, and Medicine
Stanford University School of Medicine

Joseph C. Wu, MD, PhD

Simon H. Stertzer Professor of Medicine & Radiology; Director, Stanford CVI
Stanford University School of Medicine

Colleen Clancy, PhD

Professor, Department of Pharmacology
University of California, Davis

 

Peter S. Kim, PhD

Virginia and D. K. Ludwig Professor of Biochemistry
Stanford University School of Medicine


Jonathan Fox, MD, PhD

Chief Medical Officer
MyoKardia

Sam Gambhir, MD, PhD

Virginia & D.K. Ludwig Professor For Clinical Investigation In Cancer Research
Stanford University School of Medicine
 

Philip Sager, MD

Chair
FDA Cardiorenal Drugs Advisory Committee

Mark Mercola, PhD

Professor
Stanford University School of Medicine

 

Schedule

Regulatory Policy and Clinical Trials

Norman Stockbridge, MD PhD | "What Level of Risk Aversion is Sensible in Drug Development?" | Video | Presentation (pdf)

Robert Harrington, MD | "Re-thinking Randomized Control Trials" | Video | Presentation (pdf)

Kelly A. Shepard, PhD | CIRM 2.0 - A New Funding Paradigm for Stem Cell R&D | Video | Presentation (pdf)

Christopher Austin, MD (keynote) | "Catalyzing Translational Innovation" | Video | Presentation (pdf)

Regulatory Policy and Clinical Trials Group Q&A and Panel Discussion | Moderator: Kevin Grimes, MD | Video |

Industry Leaders

Aarif Khakoo, MD |  "Translating Insights From Human Genetics to Drug Development" | Video (requires SUNet ID) |  

Bradley P. Morgan, PhD | "Modulation of Muscle Contractility" | Video (requires SUNet ID) | Presentation (requires SUNet ID)

Charles Homcy, MD | "Third Rock Ventures’ Approach to Building Therapeutic Companies" | Video (requires SUNet ID) |

Peter Kim, PhD | "Preventing Diseases with Vaccines" | Video (requires SUNet ID) | Presentation (requires SUNet ID)

Industry Leaders Group Q&A and Panel Discussion | Moderator: Jonathan Fox, MD, PhD | Video |

Oncology Research

Jennifer Grandis, MD | "STAT3 as a Cancer Drug Target" | Video (requires SUNet ID) | Presentation (requires SUNet ID)

Chaitan Khosla, PhD | "Discovery and Engineering of Novel Immunomodulatory Natural Products from the Microbiome"

Amato Giaccia, PhD | "Targeting HIF pathway to inhibit Metastasis and increase the Efficacy of Radiotherapy"

Sam Gambhir, MD, PhD | "Molecular Imaging of the Immune System in Humans" | Video (requires SUNet ID) | Presentation (requires SUNet ID)

Oncology Research Q&A and Panel Discussion | Moderator: Sanjay Malhotra, PhD | Video (requires SUNet ID) |

Cardiovascular Research

Russ Altman, MD | "Informatics Methods to Understand the Effects (Good and Bad) of Small Molecule Drugs" | Video |  

Colleen Clancy, PhD | "Cardio-pharmacology - From Molecule to Cardiac Rhythm"

Mark Mercola, PhD | "Physiological Screening for Heart Failure Drug Discovery" | Video (requires SUNet ID) | Presentation (requires SUNet ID)

Joseph Wu, MD PhD | "Patient-Specific iPSCs for Precision Cardiovascular Medicine" | Video |

Cardiovascular Research Q&A Panel Discussion | Moderator: Philip Sager, MD | Video |

Blue Sky Talks

Jessica L. Mega, MD, MPH (keynote) | "Using New Technologies and Analytic Tools to Enhance Drug Discovery and Development"

Brian Kobilka, MD (keynote) | "Challenges in GPCR Drug Discovery"

Snapshots of the Day

Organizers

Joseph Wu, MD, PhD


Sanjay Malhotra, PhD


Ingrid Ibarra, PhD


Supported by

 

Stanford Cardiovascular Institute


 

Stanford Cancer Institute


 

California Institute for Regenerative Medicine (CIRM)